SAFETY AND EFFICACY OF AMIODARONE - THE LOW-DOSE PERSPECTIVE

[11] LONG-TERM MANAGEMENT OF SUSTAINED, RECURRENT, SYMPTOMATIC VENTRICULAR-TACHYCARDIA WITH AMIODARONE [J]. CIRCULATION, 1981, 64 (02) : 273 - 279

[12] PROSPECTIVE EVALUATION OF AMIODARONE PULMONARY TOXICITY [J]. CHEST, 1984, 86 (04) : 541 - 548

[13] LEAR D, 1979, ARCH INTERN MED, V139, P425

[14] VALUE OF HOLTER MONITORING IN IDENTIFYING RISK FOR SUSTAINED VENTRICULAR ARRHYTHMIA RECURRENCE ON AMIODARONE [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (06) : 709 - 712

[15] AMIODARONE VERSUS AMIODARONE AND A TYPE-IA AGENT FOR TREATMENT OF PATIENTS WITH RAPID VENTRICULAR-TACHYCARDIA [J]. CIRCULATION, 1986, 74 (05) : 1037 - 1043

[16] AMIODARONE PULMONARY TOXICITY [J]. ANNALS OF INTERNAL MEDICINE, 1982, 97 (06) : 839 - 845

[17] MASON JW, 1985, CIRCULATION, V72, P272

[18] THE EFFICACY OF AMIODARONE FOR VENTRICULAR ARRHYTHMIAS CAN BE PREDICTED WITH CLINICAL ELECTRO-PHYSIOLOGICAL STUDIES [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1983, 3 (01) : 71 - 76

[19] AMIODARONE IN THE MANAGEMENT OF PATIENTS WITH VENTRICULAR-TACHYCARDIA AND VENTRICULAR-FIBRILLATION [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1983, 6 (03): : 609 - 615

[20] ANTIARRHYTHMIC EFFICACY AND ELECTROPHYSIOLOGIC ACTIONS OF AMIODARONE IN PATIENTS WITH LIFE-THREATENING VENTRICULAR ARRHYTHMIAS - POTENT SUPPRESSION OF SPONTANEOUSLY OCCURRING TACHYARRHYTHMIAS VERSUS INCONSISTENT ABOLITION OF INDUCED VENTRICULAR-TACHYCARDIA [J]. AMERICAN HEART JOURNAL, 1982, 103 (06) : 950 - 959

[11] LONG-TERM MANAGEMENT OF SUSTAINED, RECURRENT, SYMPTOMATIC VENTRICULAR-TACHYCARDIA WITH AMIODARONE [J]. CIRCULATION, 1981, 64 (02) : 273 - 279

[12] PROSPECTIVE EVALUATION OF AMIODARONE PULMONARY TOXICITY [J]. CHEST, 1984, 86 (04) : 541 - 548

[13] LEAR D, 1979, ARCH INTERN MED, V139, P425

[14] VALUE OF HOLTER MONITORING IN IDENTIFYING RISK FOR SUSTAINED VENTRICULAR ARRHYTHMIA RECURRENCE ON AMIODARONE [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (06) : 709 - 712

[15] AMIODARONE VERSUS AMIODARONE AND A TYPE-IA AGENT FOR TREATMENT OF PATIENTS WITH RAPID VENTRICULAR-TACHYCARDIA [J]. CIRCULATION, 1986, 74 (05) : 1037 - 1043

[16] AMIODARONE PULMONARY TOXICITY [J]. ANNALS OF INTERNAL MEDICINE, 1982, 97 (06) : 839 - 845

[17] MASON JW, 1985, CIRCULATION, V72, P272

[18] THE EFFICACY OF AMIODARONE FOR VENTRICULAR ARRHYTHMIAS CAN BE PREDICTED WITH CLINICAL ELECTRO-PHYSIOLOGICAL STUDIES [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1983, 3 (01) : 71 - 76

[19] AMIODARONE IN THE MANAGEMENT OF PATIENTS WITH VENTRICULAR-TACHYCARDIA AND VENTRICULAR-FIBRILLATION [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1983, 6 (03): : 609 - 615

[20] ANTIARRHYTHMIC EFFICACY AND ELECTROPHYSIOLOGIC ACTIONS OF AMIODARONE IN PATIENTS WITH LIFE-THREATENING VENTRICULAR ARRHYTHMIAS - POTENT SUPPRESSION OF SPONTANEOUSLY OCCURRING TACHYARRHYTHMIAS VERSUS INCONSISTENT ABOLITION OF INDUCED VENTRICULAR-TACHYCARDIA [J]. AMERICAN HEART JOURNAL, 1982, 103 (06) : 950 - 959